Premenopausal Antimüllerian Hormone Concentration is Associated with Subsequent Atherosclerosis

Overview

Journal Menopause

Specialty Gynecology & Obstetrics

Date 2012 Aug 30

PMID 22929037

Citations 20

Authors

Susan E Appt

Haiying Chen

Thomas B Clarkson

Jay R Kaplan

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to determine if premenopausal ovarian reserve is associated with susceptibility for atherosclerosis.

Methods: Female cynomolgus macaques (n = 66, women's equivalent age = 45 y) consumed an atherogenic diet for ∼5 months before the measurement of a marker of ovarian reserve (antimüllerian hormone [AMH]), plasma lipids, follicular phase estradiol, and body weight (BW). Monkeys were then ovariectomized (OVX; n = 17), remained premenopausal (n = 20), or were induced to have reduced ovarian reserve (ROR, n = 29). After 26 additional months consuming the diet, atherosclerosis measurements and risk variables were reassessed.

Results: No differences in baseline AMH, plasma lipids, BW, and estradiol or postdiet lipids and BW were observed among the groups subsequently assigned to the OVX, premenopausal control, or reduced ovarian reserve conditions. Postdiet measurements of atherosclerosis extent did not differ among the groups. However, analysis of plaque size by tertile of baseline AMH revealed that plaques were largest in monkeys that began the experiment with the lowest baseline AMH, followed by those in the middle and high tertiles (plaque extent: low AMH, 0.76 ± 0.12 mm; mid AMH, 0.46 ± 0.1 mm; high AMH, 0.34 ± 0.08 mm; P = 0.02). Baseline AMH and plaque size were also correlated negatively (r = -0.31, P = 0.01). Plasma lipids were also correlated significantly with plaque extent (all P < 0.01) but not with AMH.

Conclusions: We report for the first time an inverse relationship between a marker of ovarian reserve (AMH) and subsequent atherosclerosis risk.

Citing Articles

Sex-biased TGFβ signalling in pulmonary arterial hypertension.

Wits M, Becher C, de Man F, Sanchez-Duffhues G, Goumans M Cardiovasc Res. 2023; 119(13):2262-2277.

PMID: 37595264 PMC: 10597641. DOI: 10.1093/cvr/cvad129.

Correlation Between Serum AMH Levels and Cardiometabolic Indices in PCOS Women.

Mitra S, Saharia G, Jena S Indian J Endocrinol Metab. 2022; 25(6):545-550.

PMID: 35355916 PMC: 8959193. DOI: 10.4103/ijem.ijem_421_21.

Anti-Müllerian hormone and vascular dysfunction in women with chronic kidney disease.

Dumanski S, Anderson T, Nerenberg K, Holroyd-Leduc J, MacRae J, Raj S Physiol Rep. 2022; 10(2):e15154.

PMID: 35075809 PMC: 8787421. DOI: 10.14814/phy2.15154.

Anti-mullerian hormone attenuates insulin resistance and systemic inflammation in old obese C57BL/6 male mice.

Poursoleiman F, Zand H, Pourbadie H, Monji H, Pourvali K J Diabetes Metab Disord. 2021; 20(2):1697-1704.

PMID: 34900820 PMC: 8630344. DOI: 10.1007/s40200-021-00925-w.

Association of the functional ovarian reserve with serum metabolomic profiling by nuclear magnetic resonance spectroscopy: a cross-sectional study of ~ 400 women.

Al Rashid K, Taylor A, Lumsden M, Goulding N, Lawlor D, Nelson S BMC Med. 2020; 18(1):247.

PMID: 32862829 PMC: 7457540. DOI: 10.1186/s12916-020-01700-z.

References

Kaplan J, Adams M, Clarkson T, Koritnik D . Psychosocial influences on female 'protection' among cynomolgus macaques. Atherosclerosis. 1984; 53(3):283-95. DOI: 10.1016/0021-9150(84)90129-1. View

Ramezani Tehrani F, Solaymani-Dodaran M, Azizi F . A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause. 2009; 16(4):797-802. DOI: 10.1097/gme.0b013e318193e95d. View

Michos E, Nasir K, Braunstein J, Rumberger J, Budoff M, Post W . Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2005; 184(1):201-6. DOI: 10.1016/j.atherosclerosis.2005.04.004. View

Sowers M, Eyvazzadeh A, McConnell D, Yosef M, Jannausch M, Zhang D . Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008; 93(9):3478-83. PMC: 2567855. DOI: 10.1210/jc.2008-0567. View

Clarkson T, Mehaffey M . Coronary heart disease of females: lessons learned from nonhuman primates. Am J Primatol. 2009; 71(9):785-93. DOI: 10.1002/ajp.20693. View

Hoyer P, Sipes I . Development of an animal model for ovotoxicity using 4-vinylcyclohexene: a case study. Birth Defects Res B Dev Reprod Toxicol. 2007; 80(2):113-25. DOI: 10.1002/bdrb.20103. View

Lakatta E, Levy D . Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003; 107(1):139-46. DOI: 10.1161/01.cir.0000048892.83521.58. View

Wang M, Takagi G, Asai K, Resuello R, Natividad F, Vatner D . Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension. 2003; 41(6):1308-16. DOI: 10.1161/01.HYP.0000073843.56046.45. View

Lee R, Wu F, Lin M, Lin S, Hwu Y . The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age. Reprod Biol Endocrinol. 2011; 9:115. PMC: 3175456. DOI: 10.1186/1477-7827-9-115. View

10.

Kaplan J, Adams M, Anthony M, Morgan T, Manuck S, Clarkson T . Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol. 1995; 15(12):2094-100. DOI: 10.1161/01.atv.15.12.2094. View

11.

Modi D, Bhartiya D, Puri C . Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary. Reproduction. 2006; 132(3):443-53. DOI: 10.1530/rep.1.01178. View

12.

Deo R, Vittinghoff E, Lin F, Tseng Z, Hulley S, Shlipak M . Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. Arch Intern Med. 2011; 171(19):1703-9. PMC: 3547327. DOI: 10.1001/archinternmed.2011.328. View

13.

Gulekli B, Bulbul Y, Onvural A, Yorukoglu K, Posaci C, Demir N . Accuracy of ovarian reserve tests. Hum Reprod. 1999; 14(11):2822-6. DOI: 10.1093/humrep/14.11.2822. View

14.

Pal L, Zhang K, Zeitlian G, Santoro N . Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril. 2008; 93(4):1074-9. DOI: 10.1016/j.fertnstert.2008.10.069. View

15.

Kaplan J, Chen H, Appt S, Lees C, Franke A, Berga S . Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet. Hum Reprod. 2010; 25(12):3083-94. PMC: 2989874. DOI: 10.1093/humrep/deq288. View

16.

Xing D, Nozell S, Chen Y, Hage F, Oparil S . Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol. 2009; 29(3):289-95. PMC: 2700771. DOI: 10.1161/ATVBAHA.108.182279. View

17.

Hansen K, Hodnett G, Knowlton N, Craig L . Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2010; 95(1):170-5. DOI: 10.1016/j.fertnstert.2010.04.006. View

18.

Hansen K, Craig L, Zavy M, Klein N, Soules M . Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system. Menopause. 2011; 19(2):164-71. PMC: 3267013. DOI: 10.1097/gme.0b013e31823b0b2e. View

19.

Ethun K, Cline J, Appt S . Endocrine profile of an ovariectomized cynomolgus monkey (Macaca fascicularis) with a supernumerary ovary. Comp Med. 2012; 61(5):462-6. PMC: 3193071. View

20.

Kunt C, Ozaksit G, Kurt R, Cakir Gungor A, Kanat-Pektas M, Kilic S . Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet. 2011; 283(6):1415-21. DOI: 10.1007/s00404-011-1889-7. View